<html><head><meta charset="UTF-8"><meta content="base mri brain ms screening contrast" name="dcterms.title"><meta content="d560ab3e-2c87-4397-8110-4dc3caa5a56e" name="dcterms.identifier"><meta content="en" name="dcterms.language"><meta content="2019-01-31" name="dcterms.date"><meta content="Nuance System" name="dcterms.creator"><title>base mri brain ms screening contrast</title></head><body><section data-section-name="MRI BRAIN WITHOUT AND WITH CONTRAST, MS SCREENING"><header class="Level1">MRI BRAIN WITHOUT AND WITH CONTRAST, MS SCREENING</header><p><label>HISTORY:</label><input type="text" name="Patient Age" value="Patient Age"></p><p><label> old </label><input type="text" name="Patient Gender" value="Patient Gender"></p><p><label>, </label><input type="text" name="history" value="possible demyelinating disease."></p></section><section data-section-name="TECHNIQUE:"><header class="Level1">TECHNIQUE:</header><p><label>MR images of the brain were acquired without and with </label><input type="number" name="contrast dose"><label>mL Gadavist intravenous contrast.</label></p><p><label>COMPARISON: </label><input type="text" name="Comparison" value="None available."></p></section><section data-section-name="FINDINGS:"><header class="Level1">FINDINGS:</header><p><label>BRAIN PARENCHYMA</label><br><label>T2 hyperintense white matter lesions: </label><br><label>*Periventricular: </label><select name="periventricular"><option name="" value="">No</option><option name="" value="">1-2</option><option name="" value="">3 or more</option></select><label>lesions contacting the ependymal surface.</label></p><p><label>*Juxtacortical/Cortical: </label><select name="juxtacortical/cortical"><option name="" value="">None.</option><option name="" value="">Present.</option></select></p><p><label>*Infratentorial: </label><select name="infratentorial"><option name="" value="">None.</option><option name="Present" value="Present">Present involving the    </option></select></p><p><label>*Optic Nerve: </label><select name="optic nerve"><option name="" value="">None.</option><option name="" value="">Present.</option></select></p><p><label>*Cervicomedullary Junction: </label><select name="cervicomedullary"><option name="" value="">None.</option><option name="" value="">Present.</option></select></p><p><label>Enhancing Lesions: </label><input type="text" name="[# of enhancing lesions and locations" value="None."></p><p><label>Reduced Diffusion: </label><input type="text" name="diffusion" value="None."></p><p><label>Overall Disease Burden: </label><select name="burden"><option name="" value="">None.</option><option name="" value=""><10 lesions.</option><option name="" value="">10-20 lesions.</option><option name="" value="">>20 lesions.</option></select></p><p><label>Parenchymal Atrophy: </label><select name="parenchymal atrophy"><option name="" value="">None.</option><option name="" value="">Mild.</option><option name="" value="">Moderate.</option><option name="" value="">Severe.</option></select></p><p><label>Callosal Atrophy: </label><select name="callosal atrophy"><option name="" value="">None.</option><option name="" value="">Mild.</option><option name="" value="">Moderate.</option><option name="" value="">Severe.</option></select></p><p><label>OTHER: </label><input type="text" name="other" value="None."></p></section><section data-section-name="IMPRESSION:"><header class="Level1">IMPRESSION:</header><p><select name="impression"><option name="" value="">Normal MRI brain.</option><option name="Abnormal" value="Abnormal">Multiple white matter lesions that are consistent with demyelinating disease.</option></select></p><p><label>2016 MAGNIMS MRI criteria to establish disease dissemination in space in multiple sclerosis (Lancet Neurol. 2016 Mar;15(3):292-303)</label><br><label>Involvement of at least two of five areas of the CNS as follows:</label><br><label>* Three or more periventricular lesions</label><br><label>* One or more infratentorial lesion</label><br><label>* One or more spinal cord lesion</label><br><label>* One or more optic nerve lesion</label><br><label>* One or more cortical or juxtacortical lesio</label><br></p></section></body></html>